Nanoparticles In Vaccines?
By Mark O’Brien
An article published on globalresearch.ca describes how H1N1 Swine Flu vaccines approved by the relevant government authorities In Germany and other European countries contain nanoparticles.
Vaccine manufacturers have been experimenting with nanoparticles to virtually ‘turbocharge’ vaccines.
Researchers at the Ecole Polytechnique Fédérale de Lausanne (EPFL) announced in an article in 2007 in the journal, Nature Biotechnology, that they had developed a “nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.” (see)
Particles at a nano size, (nm = 0,000000001 metre) fuse together with the membranes of our body cell membranes and, according to recent studies in China and Japan, (see below) continuously destroy cells once introduced into the body.
Once they interact with the cell structure, they cannot be removed. Modern medicine euphemistically terms this phenomenon ‘a continuing infectious reaction‘.
Since the asbestos scandal, it has been established that particles in size a millionth of a metre, because of their enormous attractive force, penetrate all cells, destroying all those they come into contact with.
Nanoparticles are as small as one millionth of asbestos fibres.
Beijing tests confirm deadly effects on humans
The September 2009 issue of the respected European Respiratory Journal, made public on 19 August, contains a peer-reviewed article, “Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma.”
This article describes tests carried out on seven young women who were exposed at their workplace to nanoparticles.
They were each admitted to the hospital with shortness of breath and pleural effusions, or excessive fluids surrounding the lungs, inhibiting breathing.
After excluding all the other possible causes the doctors concluded this was due to their exposure to Polyacrylat nanoparticles. Two of these women died of lung complications.
“Immunological tests, examinations of bacteriology, virology and tumour markers, bronchoscopy, internal thoracoscopy and video-assisted thoracic surgery were performed.
Surveys of the workplace, clinical observations and examinations of the patients were conducted. Polyacrylate, consisting of nanoparticles, was confirmed in the workplace.
Pathological examinations of patients’ lung tissue displayed nonspecific pulmonary inflammation, pulmonary fibrosis and foreign-body granulomas of pleura.
Using transmission electron microscopy, nanoparticles were observed to lodge in the cytoplasm and caryoplasm of pulmonary epithelial and mesothelial cells, but are also located in the chest fluid.
These cases arouse concern that long-term exposure to some nanoparticles without protective measures may be related to serious damage to human lungs.“
To date animal studies and in vitro experiments show that nanoparticles can result in lung damage and other toxicity in animals, but no reports on the clinical toxicity in humans due to nanoparticles prior to the Beijing study had been made.
The Beijing Chaoyang Hospital study has now conclusively confirmed that nanoparticles cause lung damage and other toxicity in humans as well.
Once more it seems that the desire for profit is outweighing public safety. In Australia we will never be informed of the presence in vaccines of nanoparticles – we will just be told that the appropriate medical authorities have decreed that this is safe, and that anyone who questions it is anti public health.
Adapted by Mark O’Brien from Nano Particles used in Untested H1N1 Swine Flu Vaccines by F. William Engdahl
See also on this website,
Leave your comment about Nanoparticles In Vaccines? below or share with your friends on Facebook